venVelo, one of the most active early-stage venture funds in central Florida, announced today it had approved additional investments in three of its current portfolio companies, Spectrum Bridge, Vigilant Biosciences, and Zentila. venVelo’s investments and those of its Board members in just these three companies now totals over $2 million.
“When we talk about ‘watering the flowers’, these three portfolio companies – and several of our others – epitomize this strategy,” said Allen H. Kupetz, COO and co-founder of venVelo. “We see strong management teams executing on sales forecasts and we want to continue to fuel their growth.”
venVelo’s other portfolio investments are Fattmerchant, flexReceipts, GENICON, Kairos, Knetik Media (which acquired Splyt), mCast Networks, and Thrive Frozen Nutrition.